GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » EPS without NRI

Cogentix Medical (Cogentix Medical) EPS without NRI : $-0.00 (TTM As of Dec. 2017)


View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical EPS without NRI?

Cogentix Medical's earnings per share without non-recurring items for the three months ended in Dec. 2017 was $0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Cogentix Medical's EPS without NRI or its related term are showing as below:

CGNT's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.65
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Cogentix Medical's EPS (Diluted) for the three months ended in Dec. 2017 was $0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.00.

Cogentix Medical's EPS (Basic) for the three months ended in Dec. 2017 was $0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2017 was $-0.00.


Cogentix Medical EPS without NRI Historical Data

The historical data trend for Cogentix Medical's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogentix Medical EPS without NRI Chart

Cogentix Medical Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Dec16 Dec17
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.35 -0.49 -0.71 -0.01

Cogentix Medical Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -0.02 0.01 - 0.01

Competitive Comparison of Cogentix Medical's EPS without NRI

For the Medical Devices subindustry, Cogentix Medical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogentix Medical's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's PE Ratio without NRI falls into.



Cogentix Medical EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cogentix Medical  (NAS:CGNT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Cogentix Medical EPS without NRI Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Cogentix Medical (Cogentix Medical) Business Description

Traded in Other Exchanges
N/A
Address
5420 Feltl Road, Minnetonka, MN, USA, 55343
Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.
Executives
Nachum Shamir director 12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds officer: SVP, CFO, Treasurer 5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet director 800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger director 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p. 10 percent owner 6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p. 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd 10 percent owner 6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus director 40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus director 5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein director
Kevin H Roche director
David W Anderson director 519 LYNMERE ROAD, BRYN MAWR PA 19010

Cogentix Medical (Cogentix Medical) Headlines

From GuruFocus